Israël - hébreu - Ministry of Health

pfizer pharmaceuticals israel ltd - selamectin 120 mg/ml - solution - revolution kills adult flees and prevents flee eggs from hatching for one month and is indicated for the prevention and control of flea infestations (ctanocephalides felis), prevention of heartworm disease caused by dirofilaria immitis, and the treatment and control of ear mite (otodectes cynotis) infestation in dogs and cats. revolution also is indicated for the treatment and control of sarcoptic mange ( sarcoptes scabiel) and for the control of tick (dermacentor variabilis) infestation in dogs, and the treatment of intestinal hookworm (ancylostoma tubaeform) and roundworm (toxocara cati) infections in cats. revolution is recommended for use in dogs and cats six weeks of age and older.

Israël - hébreu - Ministry of Health

taro international ltd - clotrimazole 1 % - cream - imidazole and triazole derivatives - local treatment of various fungal infections.

Israël - hébreu - Ministry of Health

abic marketing ltd - polyphenon e 10 %w/w - ointment - cutaneous treatment of external genital and perianal warts (condylomata acuminata) in immunocompetent patients from the age of 18 years.

Israël - hébreu - Ministry of Health

pfizer pharmaceuticals israel ltd - sirolimus - תמיסה (פומי) - sirolimus 1 mg/ml - sirolimus - sirolimus - rapamune is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant. it is recommended that rapamune be used initially in combination with cyclosporine microemulsion and corticosteroids for 2 to 3 months. rapamune may be continued as maintenance therapy with corticosteroids only if cyclosporine can be progressively discontinued.

Israël - hébreu - Ministry of Health

pfizer pharmaceuticals israel ltd - sirolimus - תמיסה (פומי) - sirolimus 1 mg/ml - sirolimus - sirolimus - rapamune is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant. it is recommended that rapamune be used initially in combination with cyclosporine microemulsion and corticosteroids for 2 to 3 months. rapamune may be continued as maintenance therapy with corticosteroids only if cyclosporine can be progressively discontinued.

Israël - hébreu - Ministry of Health

perrigo israel agencies ltd, israel - penciclovir - קרם - penciclovir 10 mg/g - penciclovir - penciclovir - for the topical treatment for cold sores (oral herpes).

Israël - hébreu - Ministry of Health

dover medical & scientific equipment ltd, israel - factor viii (human); von willebrand factor - אבקה וממס להכנת תמיסה להזרקה - von willebrand factor 1000 iu/vial; factor viii (human) 1000 iu/vial - coagulation factor viii

Israël - hébreu - Ministry of Health

dover medical & scientific equipment ltd, israel - factor viii (human); von willebrand factor - אבקה וממס להכנת תמיסה להזרקה - von willebrand factor 500 iu/vial; factor viii (human) 500 iu/vial - coagulation factor viii

Israël - hébreu - Ministry of Health

cts ltd - progesterone micronized - קפסולות - progesterone micronized 200 mg - progesterone - progesterone - vaginal administration: progesterone substitution for ovary deprived women in situation of total progesterone deficiency. supplementation of the luteal phase during in vitro fertilization cycles. supplementation of the luteal phase during spontaneous or induced cycles, in cases of hypofertility or primary or secondary ovarain failure, particulary through dysovulation. in cases of threatning abortion or prevention of repeated abortions due to proven luteal insufficiency. for all other progesterone indication, in the case of : adverse events due to progesterone, contraindication of the oral route of administration hepatopathy. vaginal or oral addministration: disorders related to progesterone deficit in particular menopause ( in association with estrogen therapy).

Israël - hébreu - Ministry of Health

cts ltd - progesterone - קפסולות - progesterone 100 mg - progesterone - progesterone - vaginal or oral addministration: disorders related to progesterone deficit in particular menopause ( in association with estrogen therapy).vaginal administration: progesterone substitution for ovary deprived women in situation of total progesterone deficiency. supplementation of the luteal phase during in vitro fertilization cycles. supplementation of the luteal phase during spontaneous or induced cycles, in cases of hypofertility or primary or secondary ovarain failure, particulary through dysovulation. in cases of threatning abortion or prevention of repeated abortions due to proven luteal insufficiency. for all other progesterone indications, in the case of : adverse events due to progesterone, contraindication of the oral route of administration hepatopathy.